###begin article-title 0
###xml 12 35 12 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 12 34 <span type="species:ncbi:727">Haemophilus influenzae</span>
Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 12 35 12 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 12 34 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 36 40 <span type="species:ncbi:727">NTHi</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 280 284 <span type="species:ncbi:727">NTHi</span>
Nontypeable Haemophilus influenzae (NTHi) is an important respiratory pathogen implicated as an infectious trigger in chronic obstructive pulmonary disease, but its molecular interaction with human lung epithelial cells remains unclear. Herein, we tested that the hypothesis that NTHi induces the expression of cyclooxygenase (COX)-2 and prostaglandin E2 (PGE2) via activation of p38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-kappa B in pulmonary alveolar epithelial cells.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 719 728 719 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 815 822 815 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 84 88 <span type="species:ncbi:727">NTHi</span>
###xml 514 518 <span type="species:ncbi:727">NTHi</span>
###xml 622 626 <span type="species:ncbi:727">NTHi</span>
###xml 739 744 <span type="species:ncbi:10090">mouse</span>
###xml 754 758 <span type="species:ncbi:727">NTHi</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:727">NTHi</span>
Human alveolar epithelial A549 cells were infected with different concentrations of NTHi. The phosphorylation of p38 MAPK was detected by Western blot analysis, the DNA binding activity of NF-kappa B was assessed by electrophoretic mobility shift assay (EMSA), and the expressions of COX-1 and 2 mRNA and PGE2 protein were measured by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme linked immunosorbent assay (ELISA), respectively. The roles of Toll-like receptor (TLR) 2 and TLR4, well known NTHi recognizing receptor in lung epithelial cell and gram-negative bacteria receptor, respectively, on the NTHi-induced COX-2 expression were investigated in the HEK293 cells overexpressing TLR2 and TLR4 in vitro and in the mouse model of NTHi-induced pneumonia by using TLR2 and TLR4 knock-out mice in vivo. In addition, the role of p38 MAPK and NF-kappa B on the NTHi-induced COX-2 and PGE2 expression was investigated by using their specific chemical inhibitors.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 334 343 334 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 368 375 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
###xml 143 147 <span type="species:ncbi:727">NTHi</span>
###xml 260 264 <span type="species:ncbi:727">NTHi</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:727">NTHi</span>
###xml 604 608 <span type="species:ncbi:727">NTHi</span>
NTHi induced COX-2 mRNA expression in a dose-dependent manner, but not COX-1 mRNA expression in A549 cells. The enhanced expression of PGE2 by NTHi infection was significantly decreased by pre-treatment of COX-2 specific inhibitor, but not by COX-1 inhibitor. NTHi induced COX-2 expression was mediated by TLR2 in the epithelial cell in vitro and in the lungs of mice in vivo. NTHi induced phosphorylation of p38 MAPK and up-regulated DNA binding activity of NF-kappa B. Moreover, the expressions of COX-2 and PGE2 were significantly inhibited by specific inhibitors of p38 MAPK and NF-kappa B. However, NTHi-induced DNA binding activity of NF-kappa B was not affected by the inhibition of p38 MAPK.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 123 132 123 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi induces COX-2 and PGE2 expression in a p38 MAPK and NF-kappa B-dependent manner through TLR2 in lung epithelial cells in vitro and lung tissues in vivo. The full understanding of the role of endogenous anti-inflammatory PGE2 and its regulation will bring new insight to the resolution of inflammation in pulmonary bacterial infections.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 12 35 12 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 12 34 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 36 40 <span type="species:ncbi:727">NTHi</span>
###xml 96 100 <span type="species:ncbi:727">NTHi</span>
###xml 152 160 <span type="species:ncbi:9606">children</span>
###xml 383 387 <span type="species:ncbi:727">NTHi</span>
###xml 522 526 <span type="species:ncbi:727">NTHi</span>
Nontypeable Haemophilus influenzae (NTHi) is one of common and important respiratory pathogens. NTHi causes otitis media and conductive hearing loss in children while pulmonary presence of this facultative intracellular pathogen is implicated as an infectious trigger in chronic obstructive pulmonary disease (COPD) in adults [1,2]. The emergence of antibiotic-resistance strains of NTHi and the difficulty of development of efficacious vaccines urge further efforts to understand the host response mechanisms involved in NTHi infections.
###end p 11
###begin p 12
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1016 1017 1016 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1018 1019 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1212 1213 1212 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
The respiratory epithelium is an important interface to environmental microorganisms. In addition to provide a physical barrier against microbial invasion and contribute to mucociliary clearance, respiratory epithelial cells are actively involved in inflammation and host defense of the lung in multiple ways. In particular, type 2 alveolar epithelial cells (AECs) as a defender of the alveolus are located in alveoli where they recognize invading pathogens by extracellular and intracellular receptors and contribute to host innate immunity [3-5]. Lipid metabolites of arachidonic acid such as prostaglandins have been shown to modulate immune and inflammatory responses [6,7]. Prostaglandin E2 (PGE2) is a product of the cyclooxygenase (COX) pathway. Two isoforms of COX, the constitutively expressed COX-1 and the inducible COX-2, have been identified. PGE2 is commonly thought to have proinflammatory effects on the pathogenesis of several inflammatory diseases including rheumatoid arthritis and periodontitis [7,8]. However, increasing evidence demonstrated that pulmonary PGE2 has a role in limiting the inflammatory response and tissue repair in contrast to its counterparts in other organs of the body [7].
###end p 12
###begin p 13
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 139 143 <span type="species:ncbi:727">NTHi</span>
The expression of COX-derived PGE2 and its molecular regulation depend on cell types and stimuli [9]. In the present study, we showed that NTHi induced COX-2 expression and subsequent PGE2 production via activation of p38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-kappa B in lung epithelial cells. The full understanding of the role of pulmonary endogenous anti-inflammatory mediators such as PGE2 and their regulation will bring new insight and develop novel treatment aiming at immune modulation.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Materials
###end title 15
###begin p 16
SB203580, SB202190, PDTC, SC560, and NS398 were purchased from Sigma Chemicals (CA, USA), PGE2 ELISA kit was from R&D Co. (Minneapolis, USA). All other chemicals used were of analytical grade and obtained from commercial sources.
###end p 16
###begin title 17
Isolation and identification of bacterial strain
###end title 17
###begin p 18
###xml 123 137 123 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 529 538 529 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 566 574 566 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
###xml 123 136 <span type="species:ncbi:727">H. influenzae</span>
###xml 501 505 <span type="species:ncbi:727">NTHi</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
NTHi strain was a clinical isolate from Second Affiliated Hospital of Medical School, Zhejiang University. The suspectable H. influenzae strains were confirmed by X, V and X+V factor requirement test, satellite test and API-NH identification system. Slide serum agglutination test was performed and the isolated strain was proved to not agglutinate with all the capsule antiserum of type a, b, c, d, e, and f. Finally, the isolated strain was identified by 16S rRNA gene amplification and sequencing. NTHi strain 12 was used for in vitro HEK239 cell experiments and in vivo mice experiments.
###end p 18
###begin title 19
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice experiments
###end title 19
###begin p 20
###xml 212 219 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 529 531 529 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:727">NTHi</span>
###xml 175 179 <span type="species:ncbi:727">NTHi</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:727">NTHi</span>
###xml 554 558 <span type="species:ncbi:10090">Mice</span>
###xml 597 601 <span type="species:ncbi:727">NTHi</span>
C57BL/6 and BALB/c mouse strains, background strain for TLR2 and TLR4 knock-out, respectively, and TLR2 and TLR4 knock-out mice were used for NTHi-induced COX-2 expression in NTHi-induced pneumonia model in mice in vivo. C57BL/6 mice were purchased from National Cancer Institute (NCI, NIH, USA) and TLR2 knock-out mice were kindly provide by Dr. S. Akira, and TLR4 knock-out mice were purchased from Jackson Lab. (USA). Under the anesthesia, wild-type and TLR2 and TLR4 knock-out mice were intratracheally inoculated with 1 x 107 CFU of NTHi strain 12. Mice lung tissues were collected 6 h after NTHi inoculation and mRNA expression of COX-2 was measured by quantitative RT-PCR (Q-PCR) as described below. All the animal experiments were approved by the Institutional Animal Care and Use Committee at University of Rochester.
###end p 20
###begin title 21
Cell culture and in vitro experiments
###end title 21
###begin p 22
###xml 147 149 147 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 488 490 482 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 594 596 588 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 260 264 <span type="species:ncbi:9913">calf</span>
###xml 625 629 <span type="species:ncbi:727">NTHi</span>
A human alveolar epithelial cell line A549 (ATCC-CCL-185) was a kind gift from Shanghai ZJ Bio-Tech Co. Ltd., China. A549 cells were grown in 75 cm2 polystyrene flasks with RPMI1640 (HyClone, Tauranga, New Zealand) supplemented with 10% heat-inactivated fetal calf serum (Gibco, NY, USA). A549 cells were seeded at 1 x 106 cells per well of 6-well flat-bottom, cell culture plates (Corning, NY, USA). This produced a confluent monolayer after overnight incubation at 37degreesC in a 5% CO2 humidified atmosphere. After growth medium was replaced by an antibiotic-free medium, A549 cells (1 x 106 cells/mL) were infected with NTHi (multiplicity of infection, MOI: 1, 10, 50). Inhibition experiments were carried out by 1 h pretreatment with the p38 MAPK inhibitor SB203580 (20 muM), SB202190 (10 muM), the NF-kappa B inhibitor PDTC (40 muM) or the selective COX-1 inhibitor SC560 (5 muM), COX-2 inhibitor NS398 (10 muM) before bacterial stimulation. Supernatants after incubation were collected and stored at -70degreesC freezer for ELISA detection. HEK293 cells, stably overexpressing pcDNA, TLR2, and TLR4, were kindly provided by Dr. D.T. Golenbock, and cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 0.5 mg/mL of G418, and 10 mug/mL of ciprofloxacin (Cellgro, Herndon, VA).
###end p 22
###begin title 23
Reverse transcription-polymerase chain reaction (RT-PCR)
###end title 23
###begin p 24
###xml 169 172 167 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">17 </sub>
###xml 544 549 <span type="species:ncbi:9606">human</span>
Total RNA was isolated from A549 cells with Trizol Reagent (Invitrogen, CA, USA). For cDNA synthesis, 20 muL RT mixture containing total RNA 2 mug, dNTP 1 mM/L, Olig(dt)17 prime 0.2 mug, RNasin 20 U, M-MLV reverse transcriptase 200 U was incubated at 42degreesC for 60 min, then the reverse transcriptase was inactivated at 72degreesC for 15 min. PCR amplification was performed on a PE2400 cycler (Perkin-Elmer, Massachusetts, USA). Omiga 2.0 software (Oxford Molecular, Oxford, UK) was employed to design oligonucleotide primers specific for human COX-1, COX-2 and GAPDH (an internal control). COX-1: forward: 5' AGTACCGCAAGAGGTTTGGC 3', reverse: 5' GCCGTCTTGACAATGTTAAAGC 3'; COX-2: forward: 5' GACAGTCCA CCAACTTACAAT 3', reverse: 5' CATCTCTCCATCAATTATCTGAT 3'; GAPDH: forward: 5' GTCGGTGTGAACGGATTT 3', reverse: 5' ACTCCACGACGTACTCAGC 3', with the product sizes 292 bp, 411 bp and 276 bp, respectively. The condition of PCR reactions was used as follows: 94degreesC for 5 min, then 94degreesC for 1 min; 63degreesC for COX-1, 56degreesC for COX-2 and 57degreesC for GAPDH for 1 min; 72degreesC for 45 s for 30 cycles (GAPDH) or 40 cycles (COX-1, 2) and 72degreesC for 10 min to end the reaction. PCR products were electrophoresed by 1.5% agarose gel containing ethidium bromide.
###end p 24
###begin title 25
Quantitative reverse transcription-polymerase chain reaction (Q-PCR)
###end title 25
###begin p 26
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 266 271 <span type="species:ncbi:10090">mouse</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
Total RNA was isolated by using Trizol Reagent (Invitrogen), and the reverse transcription reaction was conducted with TaqMan reverse transcription reagents (Applied Biosystems). PCR amplications were performed by using SYBR Green universal master mix for human and mouse COX-2. Reactions were amplified and quantified by using as ABI 7500 sequence detector. Relative quantity of mRNAs were obtained by using the comparative Ct method and was normalized by using TaqMan predeveloped assay reagent human cyclophilin and mouse GAPDH for human COX-2 and mouse COX-2, respectively. The primers for human COX-2 were as follows: forward: 5'GAATCATTCACCAGGCAAATTG 3' and reverse: 5' TCTGTA CTGCGGGTGGAA CA 3'. The primers for mouse COX-2 were as follows: forward: 5' CCAGCACTTCAC CCATCAGTT 3' and reverse: 5' ACCCAGGTCCTCGCTTATGA 3'.
###end p 26
###begin title 27
Western blot
###end title 27
###begin p 28
###xml 763 767 <span type="species:ncbi:9925">goat</span>
###xml 773 779 <span type="species:ncbi:9986">rabbit</span>
A549 were harvested by scrapers after stimulation of 15 min and 30 min. The cell pellets were lysed in lysis buffer (125 mM Tris, pH 6.8, 4% SDS, 20% glycerol, 100 mM dithiothreitol, and 0.5% bromophenol blue) and heated for 5 min at 95degreesC. Electrophoresis was performed at 200 V for 1 h with 12% SDS-PAGE at room temperature. Proteins were transferred to nitrocellulose membrane at 75 V for 1.5 h by wet blot at 4degreesC in Mini-Protein (Bio-Rad, California, USA). The membrane was then blocked with 5% non-fat dried milk in T-TBS for 1 h, washed three times with T-TBS and incubated with phospho-p38 MAPK antibody (Cell Signaling, Bevery, USA) at 4degreesC overnight. The blots were washed three times with T-TBS and incubated for 1 h with HRP-conjugated goat-anti-rabbit IgG (Cell Signaling) at room temperature. Immunoreactive bands were developed using an ECL chemiluminescent substrate (Pierce, Rockford, USA). Autoradiography was performed with optimized exposure times. Accordingly, p38 MAPK (Cell Signaling) was detected simultaneously to confirm equal protein load.
###end p 28
###begin title 29
Electrophoretic mobility shift assay (EMSA)
###end title 29
###begin p 30
After stimulation of A549 cells, nuclear protein was isolated using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce). Biotin-labeled consensus NF-kappa B oligonucleotides were purchased from Invitrogen (Shanghai, China). The sequence of oligo was: 5' AGTTGAGGGGACTTTCCCAGGC 3'. Briefly, EMSA binding reactions were performed by incubating 5 mug of nuclear extract with the annealed oligos according to the manufacturer's instructions (Lightshift EMSA Kit, Pierce). The reaction mixture was subjected to electrophoresis on a 5% native gel.
###end p 30
###begin title 31
Enzyme linked immunosorbent assay (ELISA)
###end title 31
###begin p 32
###xml 151 153 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
PGE2 level in cell supernatants was measured using commercially available kits (R&D Systems) according to the manufacturer's protocol. The limit of PGE2 assay was 39-5000 pg/ml.
###end p 32
###begin title 33
Statistical analysis
###end title 33
###begin p 34
###xml 140 142 138 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
All data were presented as means +/- SEM. One-way ANOVA was used for statistical analysis of the differences between the groups. A value of P < 0.05 was considered statistically significant.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi-induced COX-2 expression in A549 cells
###end title 36
###begin p 37
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 32 36 <span type="species:ncbi:727">NTHi</span>
###xml 147 151 <span type="species:ncbi:727">NTHi</span>
A549 cells were inoculated with NTHi at a MOI between 1 and 50 for 4 h, and RT-PCR analysis performed for the mRNA expression. As shown in Fig. 1, NTHi inoculation dose-dependently induced expression of COX-2 mRNA, whereas had no effect on COX-1 mRNA in A549 cells.
###end p 37
###begin p 38
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The mRNA expression of COX-2 but not COX-1 induced by NTHi in a dose-dependent manner</bold>
###xml 54 58 <span type="species:ncbi:727">NTHi</span>
###xml 147 151 <span type="species:ncbi:727">NTHi</span>
The mRNA expression of COX-2 but not COX-1 induced by NTHi in a dose-dependent manner. A549 cells were inoculated with different concentrations of NTHi, as indicated in the figure, and mRNA expression of COX-1 and COX-2 was measured by RT-PCR analysis.
###end p 38
###begin title 39
###xml 18 22 <span type="species:ncbi:727">NTHi</span>
PGE2 release from NTHi-stimulated A549 cells in a COX-2 dependent way
###end title 39
###begin p 40
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 420 422 420 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 27 31 <span type="species:ncbi:727">NTHi</span>
###xml 121 125 <span type="species:ncbi:727">NTHi</span>
###xml 299 303 <span type="species:ncbi:727">NTHi</span>
###xml 404 408 <span type="species:ncbi:727">NTHi</span>
###xml 523 527 <span type="species:ncbi:727">NTHi</span>
###xml 621 625 <span type="species:ncbi:727">NTHi</span>
To investigate the role of NTHi-induced COX-2 expression on the PGE2 production, A549 cells, first, were inoculated with NTHi at a MOI between 1 and 50 for 16 h, and PGE2 expression was measured using ELISA assay. Result demonstrated that PGE2 release from A549 cells was significantly increased by NTHi (Fig. 2). Furthermore, the pre-treatment of selective COX-2 inhibitor NS398 significantly decreased NTHi-induced PGE2 production to baseline levels, but pre-treatment of selective COX-1 inhibitor SC560 has no effect on NTHi-induced PGE2 release in lung epithelial cells A549. Taken together, these data indicate that NTHi-induced PGE2 production was mediated by COX-2 dependent pathway, but independently from COX-1 pathway.
###end p 40
###begin p 41
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NTHi-induced PGE2 expression mediated by COX-2 up-regulation</bold>
###xml 310 321 306 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p &lt; 0.05 vs</italic>
###xml 337 348 333 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p &lt; 0.05 vs</italic>
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
###xml 122 126 <span type="species:ncbi:727">NTHi</span>
###xml 350 354 <span type="species:ncbi:727">NTHi</span>
NTHi-induced PGE2 expression mediated by COX-2 up-regulation. A549 cells were inoculated with different concentrations of NTHi with or without SC560 (5 muM) and NS398 (10 muM), specific inhibitors of COX-1 and COX-2, and expression levels of PGE2 were measured by ELISA assay. Data are means +/- SEM (n = 4), *p < 0.05 vs. Mock group; **p < 0.05 vs. NTHi group at 50 MOI.
###end p 41
###begin title 42
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi-induced COX-2 expression mediated by TLR2 signaling pathway
###end title 42
###begin p 43
###xml 282 291 282 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 558 565 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 654 656 654 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 65 69 <span type="species:ncbi:727">NTHi</span>
###xml 252 256 <span type="species:ncbi:727">NTHi</span>
###xml 363 367 <span type="species:ncbi:727">NTHi</span>
###xml 528 532 <span type="species:ncbi:727">NTHi</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:727">NTHi</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:727">NTHi</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 879 883 <span type="species:ncbi:727">NTHi</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1058 1062 <span type="species:ncbi:727">NTHi</span>
Given the fact that TLR2 and TLR4 are of particular important in NTHi-induced signaling pathway and gram-negative bacteria-initiated signaling pathway in lung epithelial cells, respectively, we investigated the possible involvement of TLR2 and TLR4 in NTHi-induced COX-2 expression in vitro by using HEK293 cells overexpressing TLR2 or TLR4. As shown in Fig. 3A, NTHi-induced COX-2 expression was significantly enhanced by overexpressing TLR2, but not by overexpressing TLR4. To further investigate the role of TLR2 and TLR4 in NTHi-induced COX-2 expression in vivo, wild type, and TLR2 and TLR4 knock-out mice were intratracheally inoculated with 1 x 107 CFU of NTHi strain 12, and mRNA expression of COX-2 in lungs of infected mice were measured by Q-PCR analysis 6 h after inoculation. As shown in Fig. 3B, NTHi induced COX-2 expression in lung tissues of wild-type mice, and NTHi-induced COX-2 expression was abolished by TLR2-deficiency in TLR2 knock-out mice, but not by TLR4-deficiency in TLR4 knock-out mice. Taken together, these data indicate that NTHi-induced COX-2 expression is mediated by TLR2-dependent pathway, but independently from TLR4.
###end p 43
###begin p 44
###xml 57 66 57 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">COX-2 up-regulation mediated by TLR2 in epithelial cells <italic>in vitro </italic>and lung tissues of mice <italic>in vivo</italic></bold>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 271 282 269 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p &lt; 0.05 vs</italic>
###xml 291 303 289 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p &lt; 0.005 vs</italic>
###xml 346 348 344 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 386 389 384 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B: </bold>
###xml 475 477 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 622 624 618 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 631 633 627 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 660 662 656 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 669 671 665 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 717 719 713 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:727">NTHi</span>
###xml 305 309 <span type="species:ncbi:727">NTHi</span>
###xml 350 354 <span type="species:ncbi:727">NTHi</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:727">NTHi</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:727">NTHi</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:727">NTHi</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
COX-2 up-regulation mediated by TLR2 in epithelial cells in vitro and lung tissues of mice in vivo. A. HEK293 cells overexpressing pcDNA, TLR2, and TLR4 were inoculated with NTHi, and COX-2 mRNA expression was measured by Q-PCR analysis. Data are means +/- SEM (n = 3). *p < 0.05 vs. CON; **p < 0.005 vs. NTHi in HEK293-pcDNA. NS:non-significant vs. NTHi in HEK293-pcDNA; CON: control. B: Wild-type and TLR2 and TLR4 knock-out mice were intratracheally inoculated with 1 x 107 CFU of NTHi, and mRNA expression of COX-2 was measured from the lungs of inoculated mice 6 h after inoculation. Data are means +/- SEM (n = 3). *p < 0.05 vs. CON in wild-type mice; **p < 0.05 vs. NTHi in wild-type mice. NS: non-significant vs. NTHi in wild-type mice; CON: control.
###end p 44
###begin title 45
###xml 32 36 <span type="species:ncbi:727">NTHi</span>
p38 MAPK instantly activated by NTHi
###end title 45
###begin p 46
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 135 139 <span type="species:ncbi:727">NTHi</span>
###xml 331 335 <span type="species:ncbi:727">NTHi</span>
###xml 458 462 <span type="species:ncbi:727">NTHi</span>
To investigate the involvement of p38 MAPK signaling pathway, which is known as important component of TLR2-induced signaling pathway, NTHi-induced phosphorylation of p38 MAPK was, first, measured by using western blot analysis. As shown in Fig. 4A, the phosphorylation of p38 MAPK was induced within 15-30 min in A549 cells after NTHi inoculation, and the pre-treatment of the specific inhibitor of p38 MAPK SB203580 blocked p38 MAPK signaling activated by NTHi (Fig. 4B).
###end p 46
###begin p 47
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phosphorylation of p38 MPAK induced by NTHi</bold>
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 172 175 172 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B: </bold>
###xml 327 334 326 333 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A &amp; B: </bold>
###xml 39 43 <span type="species:ncbi:727">NTHi</span>
###xml 97 101 <span type="species:ncbi:727">NTHi</span>
###xml 217 221 <span type="species:ncbi:727">NTHi</span>
Phosphorylation of p38 MPAK induced by NTHi. A. A549 cells were inoculated with 10 and 50 MOI of NTHi, and phosphorayltion of p38 MAPK was detected by Immunoblot analysis. B: A549 cells were inoculated with 50 MOI of NTHi with or without 20 muM of SB203580, and phosphorayltion of p38 MAPK was detected by Immunoblot analysis. A & B: representative blots from three independent experiments.
###end p 47
###begin title 48
###xml 55 59 <span type="species:ncbi:727">NTHi</span>
Up-regulation of NF-kappa B DNA binding activity after NTHi stimulation
###end title 48
###begin p 49
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 151 155 <span type="species:ncbi:727">NTHi</span>
###xml 239 243 <span type="species:ncbi:727">NTHi</span>
###xml 389 393 <span type="species:ncbi:727">NTHi</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
###xml 677 681 <span type="species:ncbi:727">NTHi</span>
Since NF-kappa B signaling pathway is known as a component of TLR2 signaling pathway and down-stream of p38 signaling pathway, we investigated whether NTHi induces NF-kappa B activation in our system, and p38 MAPK is up-stream molecule of NTHi-induced NF-kappa B signaling pathway. EMSA analysis showed that NF-kappa B translocation and its DNA binding activity were markedly increased by NTHi within 90 mins, and DNA binding activity of NF-kappa B was not affected by pre-treatment of specific p38 MAPK inhibitor SB203580. These data indicate that p38 MAPK and NF-kappa B are two independent signal pathways in the regulation of host response of human lung epithelium against NTHi (Fig. 5).
###end p 49
###begin p 50
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Enhanced DNA binding activity of NF-kappa B induced by NTHi</bold>
###xml 55 59 <span type="species:ncbi:727">NTHi</span>
###xml 120 124 <span type="species:ncbi:727">NTHi</span>
Enhanced DNA binding activity of NF-kappa B induced by NTHi. A549 cells were incubated with different concentrations of NTHi with or without SB203580, and DNA binding activity of NF-kappa B was measured by EMSA analysis. A representative gel from three independent experiments with similar results is shown in figure.
###end p 50
###begin title 51
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi-induced COX-2 and PGE2 expression mediated by p38 MAPK and NF-kappa B signaling pathway
###end title 51
###begin p 52
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 25 29 <span type="species:ncbi:727">NTHi</span>
###xml 77 81 <span type="species:ncbi:727">NTHi</span>
###xml 211 215 <span type="species:ncbi:727">NTHi</span>
###xml 361 365 <span type="species:ncbi:727">NTHi</span>
###xml 559 563 <span type="species:ncbi:727">NTHi</span>
###xml 739 743 <span type="species:ncbi:727">NTHi</span>
To determine the role of NTHi-induced p38 MAPK and NF-kappa B activations in NTHi-induced COX-2 and PGE2 expression, the effects of p38 MAPK inhibitors SB203580 and SB202190 and NF-kappa B inhibitor PDTC on the NTHi-induced COX-2 mRNA expression and PGE2 production were measured by using RT-PCR analysis and ELISA assay, respectively. As shown in Fig. 6A &6B, NTHi-induced COX-2 mRNA expression was markedly inhibited by pre-treatment of NF-kappa B inhibitor PDTC and p38 MAPK inhibitors SB203580 and SB202190. Moreover, ELISA assay against PGE2 showed that NTHi-induced PGE2 expression was significantly inhibited by NF-kappa B inhibitor PDTC and p38 MAPK inhibitors SB203580 and SB202190. Taken together, these data clearly showed that NTHi-induced PGE2 expression is mediated by p38 MAPK- and NF-kappa B-dependent signaling pathway (Fig. 6C).
###end p 52
###begin p 53
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NTHi-induced COX-2 mRNA and PGE2 expression mediated by p38 MAPK- and NF-kappa B-dependent signaling pathway</bold>
###xml 110 113 110 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A: </bold>
###xml 258 261 258 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B: </bold>
###xml 416 419 416 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C: </bold>
###xml 623 625 621 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 632 634 630 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 644 646 642 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 653 655 651 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
###xml 145 149 <span type="species:ncbi:727">NTHi</span>
###xml 240 244 <span type="species:ncbi:727">NTHi</span>
###xml 398 402 <span type="species:ncbi:727">NTHi</span>
###xml 451 455 <span type="species:ncbi:727">NTHi</span>
###xml 572 576 <span type="species:ncbi:727">NTHi</span>
###xml 667 671 <span type="species:ncbi:727">NTHi</span>
NTHi-induced COX-2 mRNA and PGE2 expression mediated by p38 MAPK- and NF-kappa B-dependent signaling pathway. A: A549 cells were inoculated with NTHi with or without PDTC, and COX-2 mRNA expression was measured by RT-PCR analysis 4 h after NTHi inoculation. B: A549 cells were inoculated with p38 inhibitors SB203580 or SB202190, and COX-2 mRNA expression was measured by RT-PCR analysis 4 h after NTHi inoculation. C: A549 cells were inoculated with NTHi with or without PDTC, SB203580, and SB202190, and expression levels of PGE2 were measured by ELISA assay 16 h after NTHi inoculation. Data are means +/- SEM (n = 3). *p < 0.05 vs. Mock; **p < 0.05 vs. 50 MOI of NTHi.
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 406 430 406 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 432 452 432 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia pneumoniae</italic>
###xml 454 475 454 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Moraxella catarrhalis</italic>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 9 13 <span type="species:ncbi:727">NTHi</span>
###xml 59 67 <span type="species:ncbi:9606">children</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 406 430 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 432 452 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 454 475 <span type="species:ncbi:480">Moraxella catarrhalis</span>
###xml 481 508 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 586 590 <span type="species:ncbi:727">NTHi</span>
Although NTHi is an important respiratory pathogen in both children and adults, little is known about its molecular interaction with human lung epithelial cells. Equipped with transmembranous and cytosolic pattern recognition receptors, respiratory epithelium actively participates in immune reaction against invading pathogens instead of being only a passive physical barrier [10]. It has been shown that Streptococcus pneumoniae, Chlamydia pneumoniae, Moraxella catarrhalis, and respiratory syncytial virus induced COX-2 expression in pulmonary epithelium [9,11-13]. However, whether NTHi infections have effect on the expression of COX-2 and subsequent PGE2 in lung epithelial cells still remains uncertain.
###end p 55
###begin p 56
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 381 385 <span type="species:ncbi:727">NTHi</span>
###xml 479 483 <span type="species:ncbi:727">NTHi</span>
Lipid products of arachidonic acid including prostaglandins play important roles in pulmonary immune regulation. PGE2 released by lung cells is demonstrated as a potent endogenous anti-inflammatory mediator, which modulates host immune response [7]. But, data about the molecular mechanisms of pulmonary PGE2 expression are very limited. In the present study, we demonstrated that NTHi induced COX-2 mRNA but not COX-1 mRNA in a dose-dependent manner in A549 cells. Furthermore, NTHi-induced PGE2 release was significantly suppressed by COX-2 specific inhibitor, but not COX-1 inhibitor. These results indicated that PGE2 release depends on COX-2 activity, in line with the previous studies by Schmeck et al. and Rupp et al. [9,14].
###end p 56
###begin p 57
###xml 469 478 469 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 482 489 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 222 226 <span type="species:ncbi:727">NTHi</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:727">NTHi</span>
###xml 614 618 <span type="species:ncbi:727">NTHi</span>
TLRs are well known cell surface receptors recognizing invading microbes and initiating cellular signaling pathways against bacterial components. Among of 11 mammalian TLRs, TLR2 is recognized as an important receptor for NTHi-induced signaling pathway in lung epithelial cells. Taken advantages of stably overexpressing TLR2 and TLR4 cells and TLR2 and TLR4 knock-out mice, we showed here that NTHi-induced COX-2 expression was mediated by TLR2 signaling pathway both in vitro and in vivo, but independently from TLR4. These data are in line with previous report that TLR2 is of particular important receptor for NTHi components [15,16].
###end p 57
###begin p 58
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 539 541 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 542 544 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 726 728 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 57 61 <span type="species:ncbi:727">NTHi</span>
###xml 314 318 <span type="species:ncbi:727">NTHi</span>
###xml 820 824 <span type="species:ncbi:727">NTHi</span>
###xml 866 870 <span type="species:ncbi:727">NTHi</span>
###xml 1060 1064 <span type="species:ncbi:727">NTHi</span>
###xml 1078 1082 <span type="species:ncbi:727">NTHi</span>
###xml 1283 1287 <span type="species:ncbi:727">NTHi</span>
###xml 1527 1531 <span type="species:ncbi:727">NTHi</span>
The lung epithelial cell signaling networks activated by NTHi have been partially elucidated in recent years. Among these signaling pathways, p38 MAPK and NF-kappa B are two key molecules which coordinate the induction of multiple genes encoding inflammatory mediators and are involved in host immune responses to NTHi infections [2]. Activation of p38 MAPK up-regulates inflammatory cytokines, mucin MUC5AC and down-regulates TLR2 expression while activation of NF-kappa B increases the expression of IL-8, IL-1beta, mucin MUC2 and TLR2 [15-19]. In addition, there exists an auto-regulation of NF-kappa B activation: NF-kappa B is essential for induction of cylindromatosis (CYLD) that in turn inhibits NF-kappa B signaling [20]. However, whether p38 and NF-kappa B are involved in COX-2 and PGE2 production induced by NTHi remained unclear. Herein, we showed that NTHi activated the phosphorylation of p38 MAPK and nuclear translocation of NF-kappa B within 90 mins, and the enhanced DNA binding activity was observed in nuclear extracts of A549 cells after NTHi inoculation. NTHi-induced COX-2 mRNA expression was markedly inhibited not only by p38 MAPK inhibitor SB203580, but also by another p38 MAPK inhibitor SB202190, and NF-kappa B inhibitor PDTC. Moreover, PGE2 release by NTHi, also, was significantly reduced by both p38 MAPK inhibitors and NF-kappa B inhibitor. The findings in the present study clearly demonstrate that the activation of p38 MAPK and NF-kappa B is involved in the regulation of COX-2 and PGE2 in NTHi-infected lung epithelium.
###end p 58
###begin p 59
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1311 1312 1311 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1313 1315 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1316 1318 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 726 731 <span type="species:ncbi:9606">human</span>
In this study, we found the impact of p38 MAPK on the activation of NF-kappa B. EMSA results showed that the NF-kappa B activation was not prevented by SB203580 in infected A549 cells, indicating that p38 MAPK and NF-kappa B are independent pathways regulating PGE2 expression in our experimental systems. Mancuso et al. reported that neither p38 nor ERK MAPK blockade had any effect on Group B streptococci (GBS)-induced NF-kappa B binding activity [21]. Vallejo et al. demonstrated that p38 inhibitor SB202190 inhibited GBS-induced activator protein (AP)-1-DNA activity, but did not prevent NF-kappa B activation [22]. Similarly, the study by Singer et al. showed that p38 MAPK and NF-kappa B may affect COX-2 expression in human airway myocytes via separate signaling pathways given the fact that SB203580 did not affect cytokine-stimulated IkappaBalpha degradation and NF-kappa B nuclear binding activity [23]. However, the above results cannot exclude another possibility that there exists an indirect cross-talk between p38 MAPK and NF-kappa B which converge further down in the signal cascades [21]. Indeed, there are still increasing evidences that the blockade of MAPK inhibited NF-kappa B-dependent gene transcription without affecting IkappaBalpha phosphorylation and NF-kappa B-DNA binding ability [9,24-27].
###end p 59
###begin p 60
###xml 142 156 142 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae </italic>
###xml 159 173 159 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. pneumoniae </italic>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 36 40 <span type="species:ncbi:727">NTHi</span>
###xml 142 155 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 159 172 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 535 539 <span type="species:ncbi:727">NTHi</span>
###xml 718 722 <span type="species:ncbi:727">NTHi</span>
###xml 756 760 <span type="species:ncbi:727">NTHi</span>
###xml 804 808 <span type="species:ncbi:727">NTHi</span>
###xml 884 888 <span type="species:ncbi:727">NTHi</span>
###xml 969 973 <span type="species:ncbi:727">NTHi</span>
###xml 1099 1103 <span type="species:ncbi:727">NTHi</span>
In our study, the fold induction of NTHi-induced PGE2 production was relatively low compared with those from other studies conducted by using S. pneumoniae or C. pneumoniae infection model [9,14], possibly due to the different signaling pathways mediated. However, the absolute amount of PGE2 production measured in our study in lung epithelial cells A549 is quite equivalent to those from other studies [28,29]. In addition to this, little is known about the patho-physiological role of the prostanoid intermediates including PGE2 in NTHi infections due to the absence of research information in this field. Thus, even though we could not rule the involvement of other prostanoid intermediates such as PGF and PGI in NTHi infections, we suggest here that NTHi-induced PGE2 may play an important role in NTHi infection. Further studies in the detailed molecular mechanisms underlying NTHi-induced PGE2 expression and in the pathological analysis of the role of PGE2 in NTHi infection based on the findings from present study will bring us novel insights into the therapeutic strategies of pulmonary NTHi infections.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 138 147 138 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 164 171 164 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 15 19 <span type="species:ncbi:727">NTHi</span>
###xml 334 338 <span type="species:ncbi:727">NTHi</span>
In conclusion, NTHi induces COX-2 and PGE2 expression in a p38 MAPK and NF-kappa B-dependent manner through TLR2 in lung epithelial cells in vitro and lung tissues in vivo. The full understanding of the role of endogenous anti-inflammatory PGE2 and its regulation will bring new insight to the resolution of inflammation in pulmonary NTHi infections.
###end p 62
###begin title 63
Competing interests
###end title 63
###begin p 64
The author(s) declare that they have no competing interests.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
###xml 227 235 227 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 155 159 <span type="species:ncbi:727">NTHi</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
FX planned the experimental design, carried out Western blot, EMSA and drafted the manuscript. ZHX participated in cell culture and RT-PCR. RZ carried out NTHi isolation and identification. ZQW carried out ELISA. LJH performed in vivo mice experiments. KT carried out Q-PCR. JDL participated in the study design and helped to draft the manuscript. HHS participated in the study design and coordinated the research group. All authors read and approved the final manuscript.
###end p 66
###begin title 67
Acknowledgements
###end title 67
###begin p 68
This project was supported by a grant from the National Natural Science Foundation of China (No. 30500229).
###end p 68
###begin article-title 69
Infectious etiology of acute exacerbations of chronic bronchitis
###end article-title 69
###begin article-title 70
Exploitation of host epithelial signaling networks by respiratory bacterial pathogens
###end article-title 70
###begin article-title 71
Epithelial cells as sensors for microbial infection
###end article-title 71
###begin article-title 72
Mucus clearance as a primary innate defense mechanism for mammalian airways
###end article-title 72
###begin article-title 73
Series introduction: innate host defense of the respiratory epithelium
###end article-title 73
###begin article-title 74
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
###end article-title 74
###begin article-title 75
The lung as a privileged site for the beneficial actions of PGE2
###end article-title 75
###begin article-title 76
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
###end article-title 76
###begin article-title 77
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium
###end article-title 77
###begin article-title 78
Lung epithelial as a sentinel and effector system in pneumonia-molecular mechanisms of pathogen recognition and signal transduction
###end article-title 78
###begin article-title 79
###xml 55 75 55 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia pneumoniae</italic>
###xml 55 75 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Infection and activation of airway epithelial cells by Chlamydia pneumoniae
###end article-title 79
###begin article-title 80
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Moraxella catarrhalis </italic>
###xml 0 21 <span type="species:ncbi:480">Moraxella catarrhalis</span>
Moraxella catarrhalis induces ERK- and NF-kappaB-dependent COX-2 and prostaglandin E2 in lung epithelium
###end article-title 80
###begin article-title 81
###xml 0 27 <span type="species:ncbi:12814">Respiratory syncytial virus</span>
###xml 29 32 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 93 96 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy
###end article-title 81
###begin article-title 82
###xml 27 47 27 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia pneumoniae</italic>
###xml 59 61 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 27 47 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression
###end article-title 82
###begin article-title 83
###xml 40 63 40 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 40 62 <span type="species:ncbi:727">Haemophilus influenzae</span>
Activation of NF-kappa B by Nontypeable Haemophilus influenzae is mediated by TLR2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells
###end article-title 83
###begin article-title 84
###xml 52 74 52 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae</italic>
###xml 52 74 <span type="species:ncbi:727">Haemophilus influenzae</span>
Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase
###end article-title 84
###begin article-title 85
###xml 52 75 52 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 52 74 <span type="species:ncbi:727">Haemophilus influenzae</span>
Synergistic activation of NF-kappa B by nontypeable Haemophilus influenzae and tumor necrosis factor-alpha
###end article-title 85
###begin article-title 86
The transforming growth factor-beta-Smad3/4 signaling pathway acts as a positive regulator for TLR2 induction by bacteria via a dual-mechanism involving functional cooperation with NF-kappaB and MAPK phosphatase 1-dependent negative cross-talk with p38 MAPK
###end article-title 86
###begin article-title 87
###xml 42 65 42 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 42 64 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 MAP kinase pathway and a negative PI 3-Kinase-Akt pathway
###end article-title 87
###begin article-title 88
NF-kappaappaB is essential for induction of CYLD, the negative regulator of NF-kappaappaB: evidence for a novel inducible autoregulatory feedback pathway
###end article-title 88
###begin article-title 89
Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci
###end article-title 89
###begin article-title 90
###xml 138 143 <span type="species:ncbi:9606">human</span>
Group B Streptococcus induces TNF-alpha gene expression and activation of the transcription factors NF-kappa B and activator protein-1 in human cord blood monocytes
###end article-title 90
###begin article-title 91
###xml 51 56 <span type="species:ncbi:9606">human</span>
p38 MAPK and NF-kappaB mediate COX-2 expression in human airway myocytes
###end article-title 91
###begin article-title 92
p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor
###end article-title 92
###begin article-title 93
IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha induced kappaB-dependent transcription. Requirement for an additional activation pathway
###end article-title 93
###begin article-title 94
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 90 112 90 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycoplasma fermentans </italic>
###xml 90 111 <span type="species:ncbi:2115">Mycoplasma fermentans</span>
Signal transduction pathways involved in the activation of NF-kappa B, AP-1, and c-fos by Mycoplasma fermentans membrane lipoproteins in macrophages
###end article-title 94
###begin article-title 95
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor
###end article-title 95
###begin article-title 96
###xml 81 86 <span type="species:ncbi:9606">human</span>
Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils
###end article-title 96
###begin article-title 97
###xml 60 84 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Glial cells production of inflammatory mediators induced by Streptococcus pneumoniae: inhibition by pentoxifylline, low-molecular-weight heparin and dexamethasone
###end article-title 97

